SOD1 and amyotrophic lateral sclerosis: Therefore, their experiments and immunohistochemical analysis in the brain and spinal cord capillaries of SOD rats suggested that any treatment should not be from P-glycoproteins substrates to improve therapeutic efficacy in the CNS during ALS progression [256].